Once Weekly (QW) Basal Insulin Fc (BIF) and Daily Degludec (DEG) Achieve Comparable Glycemic Control in Three Patient Populations Studied during Phase 2-Clinical Insights from CGM Assessments

被引：0
|
作者：
Kazda, Christof M.
Bue-Valleskey, Juliana M.
Zhang, Qianyi
Haupt, Axel
Frias, Juan P.
Dahl, Dominik
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-806-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
806-P
引用
收藏
页数：2
相关论文
共 6 条
  • [1] Once-weekly insulin efsitora alfa and daily degludec achieve comparable glycaemic control in 3 patient populations during phase 2: clinical insights from CGM assessments
    Kazda, C.
    Bue-Valleskey, J.
    Zhang, Q.
    Haupt, A.
    Frias, J.
    Dahl, D.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S8 - S8
  • [2] Once Weekly (QW) Basal Insulin Fc (BIF) Demonstrated Similar Glycemic Control to Once Daily (QD) Insulin Degludec (DEG) in Insulin-Naive Patients with Type 2 Diabetes (T2D)
    Bue-Valleskey, Juliana M.
    Kazda, Christof M.
    Ma, Chenchen
    Chien, Jenny
    Zhang, Qianyi
    Chigutsa, Emmanuel
    Landschulz, William
    Swan, Jennifer
    Haupt, Axel
    Frias, Juan Pablo
    DIABETES, 2022, 71
  • [3] ONCE-WEEKLY BASAL INSULIN FC (BIF) DEMONSTRATED SIMILAR GLYCEMIC CONTROL TO ONCE-DAILY INSULIN DEGLUDEC (DEG) IN INSULIN-NAIVE PATIENTS WITH TYPE 2 DIABETES (T2D)
    Bue-Valleskey, J.
    Kazda, C.
    Ma, C.
    Chien, J.
    Zhang, Q.
    Chigutsa, E.
    Landschulz, W.
    Swan, J.
    Haupt, A.
    Frias, J. P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A193 - A193
  • [4] Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial
    Bue-Valleskey, Juliana M.
    Kazda, Christof M.
    Ma, Chenchen
    Chien, Jenny
    Zhang, Qianyi
    Chigutsa, Emmanuel
    Landschulz, William
    Haupt, Axel
    Frias, Juan P.
    DIABETES CARE, 2023, 46 (05) : 1060 - 1067
  • [5] Initiation of Once-Weekly (QW) Basal Insulin Fc (BIF) in Three Patient Populations in Phase 2 Studies Using a One-Time Loading Dose (LD) Minimizes Transient Hyperglycemia and Is Not Associated with Excess Hypoglycemia Risk vs. Degludec
    Bue-Valleskey, Juliana M.
    Kazda, Christof M.
    Zhang, Qianyi
    Haupt, Axel
    Dahl, Dominik
    Frias, Juan P.
    DIABETES, 2023, 72
  • [6] Glycemic Control with Once-Weekly Basal Insulin Fc (BIF) in Persons with Type 2 Diabetes Mellitus (T2DM) Using Continuous Glucose Monitoring (CGM) in a Phase 2 Study
    Kazda, Christof M.
    Chien, Jenny
    Zhang, Qianyi
    Chigutsa, Emmanuel
    Landschulz, William
    Wullenweber, Paula
    Haupt, Axel
    Frias, Juan P.
    DIABETES, 2021, 70
1